ANAVEX LIFE SCIENCES CORP. (AVXL) Current Ratio
- Current ratio · latest quarter: Value 4.55×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2020-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.55× | Current assets / current liabilities. $31.63M ÷ $6.95M ≈ 4.55× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 31.63M USD | Assets, Current |
| Current obligations | 6.95M USD | Liabilities, Current |
| Cash and equivalents | 27.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 3.98M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $31.63M | $6.95M | $27.62M | (m) | (m) | (m) | $3.98M | (m) | 4.55× |
| 2019-09-30 | $25.33M | $5.04M | $22.19M | (m) | (m) | (m) | $3.52M | (m) | 5.03× |
| 2019-06-30 | $21.82M | $4.34M | $21.25M | (m) | (m) | (m) | (m) | (m) | 5.03× |
| 2019-03-31 | $20.55M | $6.37M | $19.46M | (m) | (m) | (m) | (m) | (m) | 3.23× |
| 2018-12-31 | $22.10M | $4.88M | $20.72M | (m) | (m) | (m) | (m) | (m) | 4.53× |
| 2018-09-30 | $26.05M | $3.88M | $22.93M | (m) | (m) | (m) | $2.96M | (m) | 6.71× |
| 2018-06-30 | $26.74M | $3.21M | $25.83M | (m) | (m) | (m) | (m) | (m) | 8.33× |
| 2018-03-31 | $25.81M | $3.42M | $25.66M | (m) | (m) | (m) | (m) | (m) | 7.55× |
| 2017-12-31 | $28.29M | $2.80M | (m) | (m) | (m) | (m) | (m) | (m) | 10.11× |
| 2017-09-30 | $27.79M | $3.58M | $27.44M | (m) | (m) | (m) | (m) | (m) | 7.75× |
| 2017-06-30 | $24.85M | $1.45M | (m) | (m) | (m) | (m) | (m) | (m) | 17.09× |
| 2017-03-31 | $23.55M | $2.12M | (m) | (m) | (m) | (m) | (m) | (m) | 11.11× |
| 2016-12-31 | $21.32M | $2.19M | (m) | (m) | (m) | (m) | (m) | (m) | 9.71× |
| 2016-06-30 | $9.84M | $2.17M | (m) | (m) | (m) | (m) | (m) | (m) | 4.53× |
| 2016-03-31 | $12.11M | $2.43M | (m) | (m) | (m) | (m) | (m) | (m) | 4.98× |
| 2015-12-31 | $14.02M | $2.53M | (m) | (m) | (m) | (m) | (m) | (m) | 5.54× |
| 2015-09-30 | $15.47M | $2.66M | (m) | (m) | (m) | (m) | (m) | (m) | 5.81× |
| 2015-06-30 | $7.98M | $1.35M | (m) | (m) | (m) | (m) | (m) | (m) | 5.90× |
| 2015-03-31 | $6.36M | $1.53M | (m) | (m) | (m) | (m) | (m) | (m) | 4.16× |
| 2014-12-31 | $7.05M | $1.42M | (m) | (m) | (m) | (m) | (m) | (m) | 4.97× |
| 2014-09-30 | $7.35M | $1.44M | (m) | (m) | (m) | (m) | (m) | (m) | 5.10× |
| 2014-06-30 | $8.20M | $1.90M | (m) | (m) | (m) | (m) | (m) | (m) | 4.31× |
| 2014-03-31 | $9.22M | $1.88M | (m) | (m) | (m) | (m) | (m) | (m) | 4.90× |
| 2013-12-31 | $148.75K | $1.82M | (m) | (m) | (m) | (m) | (m) | (m) | 0.08× |
| 2013-09-30 | $393.45K | $1.95M | (m) | (m) | (m) | (m) | (m) | (m) | 0.20× |
| 2012-09-30 | $12.58K | $2.89M | (m) | (m) | (m) | (m) | (m) | (m) | 0.00× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |